Literature DB >> 16540378

Locally administered antiproliferative drugs inhibit hypercontractility to serotonin in balloon-injured pig coronary artery.

Simon Kennedy1, Roger M Wadsworth, Cherry L Wainwright.   

Abstract

Although drugs such as sirolimus and paclitaxel are effective in reducing restenosis, their effects on vascular function are often overlooked. In this study, we have examined the effects of local delivery of several anti-restenotic drugs given in vivo after balloon injury on in vitro vascular contraction and relaxation 28 days after injury. Paclitaxel (50 microM), the farnesyl protein transferase inhibitor L744 (25 microM), sirolimus (25 microM) and Van 10/4 (decahydro-1,1,4,7-tetramethyl-1H-cycloprop[e]azulen-4-o-[2-(3-methylpent-2-enoyl)-fucopyranoside]; 25 microM) were delivered to porcine coronary arteries in vivo and the arteries removed 28 days later. Contractions to KCl and 5-hydroxytryptamine (5-HT) and relaxations to calcimycin and 3-morpholinosydnonimine (SIN-1) were measured in control (LCx) and balloon-injured (LAD) rings. In vehicle-infused coronary arteries, contraction to KCl and 5-HT was significantly enhanced 28 days after balloon injury, while the response to calcimycin had recovered fully, indicating endothelial regrowth. The response to SIN-1 was unchanged. None of the four drugs tested had any effect on the enhanced response to KCl 28 days after injury or on recovery of the calcimycin response. The hyper-responsiveness to 5-HT was eliminated by sirolimus, Van 10/4 and L744, but not paclitaxel. This study demonstrates that local drug infusion with structurally different antiproliferative drugs at the time of balloon angioplasty does not affect endothelial recovery and may in some cases prevent hyper-responsiveness to constrictor agents.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16540378     DOI: 10.1016/j.vph.2006.01.012

Source DB:  PubMed          Journal:  Vascul Pharmacol        ISSN: 1537-1891            Impact factor:   5.773


  2 in total

1.  The sphingosine kinase inhibitor N,N-dimethylsphingosine inhibits neointimal hyperplasia.

Authors:  Robert A McDonald; Susan Pyne; Nigel J Pyne; Anne Grant; Cherry L Wainwright; Roger M Wadsworth
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

2.  Inhibition of 5-Hydroxytryptamine Receptor 2B Reduced Vascular Restenosis and Mitigated the β-Arrestin2-Mammalian Target of Rapamycin/p70S6K Pathway.

Authors:  Yahan Liu; Zhipeng Wang; Jing Li; Yiqian Ban; Guangmei Mao; Man Zhang; Mo Wang; Yan Liu; Beilei Zhao; Qiang Shen; Qingbo Xu; Nanping Wang
Journal:  J Am Heart Assoc       Date:  2018-01-30       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.